Filter
47
Featured
Language
Document type
No document type
24
Guidelines
15
Fact sheets
4
Studies & Reports
2
Manuals
1
Resource Platforms
1
Countries / Regions
South Africa
2
Latin America and the Carribbean
2
Western and Central Europe
2
Cambodia
1
Ukraine
1
Africa
1
Laos
1
Vietnam
1
Authors & Publishers
World Health Organization WHO
14
World Health Organization
11
et al.
5
i-base
4
European AIDS Clinical Society (EACS)
2
M. Vitoria
2
Organización Panamericana de la Salud
2
P. Clayden
2
UNAIDS
2
World Health Organization (WHO)
2
A. Adesina
1
A. Gupta
1
B. Dongmo-Nguimfack
1
Clinical Info HIV
1
D. K. Mubangizi
1
Deparment of Health, South Africa
1
HIV i-Base
1
J Acquir Immune Defic Syndr
1
J. Stover
1
L. Myer
1
M. Auton
1
M. Doherty
1
M. Penazzato
1
M. Smid
1
M. Stahl
1
M. Vitoriaa
1
Médecins Sans Frontières
1
MSF Access Campaign
1
MSF Médecins sans Frontières
1
N. Forda
1
National Department of Health South Africa
1
OPS
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud (Americas)
1
PAHO
1
Pan American Health Organisation PAHO
1
PLOS ONE
1
S. Juneja
1
T. K. Phillips
1
Ukraine Ministry of Health
1
Unitaid
1
WHO (World Health Organisation)
1
Wolters Kluwer Health
1
World Health Organization (Africa)
1
Publication Years
Category
Clinical Guidelines
12
Countries
6
Pharmacy & Technologies
1
The federally approved clinical practice guidelines for HIV/AIDS are developed by panels of experts in HIV care. More information about the panels can be found in each set of guidelines. The recommendations in these guidelines represent the current, evidence-based consensus of the U.S. Departmen ... more
СТАНДАРТ МЕДИЧНОЇ ДОПОМОГИ. These clinical guidelines, released by the Ukraine Ministry of Health in 2025, include the latest recommendations for HIV services, including oral PrEP and injectable cabotegravir (CAB) for PrEP.
This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral therapy, preventing vertical transmission, and enhancing tuberculosis prevention among individuals with HIV. These updates are intended to ... more
Questions and answers. A key priority is preventing the interruption of current HIV treatment and prevention medicines. This Q&A outlines advice when this is not possible. Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes. The latest data on safety and efficacy of do ... more
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w ... more
This technical note summarizes the consolidated guidelines and adapts them to the context of Latin America and the Caribbean, in order to adequately monitor the number of people on ART. For this purpose, guidance is presented on the indicators and the methodology to know more precisely the number of ... more
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w ... more